Home › Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A
 

Keywords :   


Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A

2014-06-23 15:03:42| Chemicals - Topix.net

Dimension Therapeutics, a company focused on developing novel adeno-associated virus gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare for the development and commercialization of a novel gene therapy for the treatment of hemophilia A .

Tags: partner develop therapy gene

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
09.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
08.11Statement from the U.S. Green Building Council on the 2024 Election Results
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
Chemicals »
15.11
15.11BELLE
15.11 Blu-ray 3
15.11LJN
15.11 vol.8
15.11 Kondo KRS-2552R2HV ICS
15.11 Lunatic Blood / Kleio
15.11111
More »